North Atlantic Smlr Co Inv Tst PLC
26 September 2003
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1. Name of company
North Atlantic Smaller Companies Investment Trust PLC
2. Name of director
C H B Mills
3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18 or in respect of a non-beneficial
interest
As in 2 above
4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them (if notified)
5. Please state whether notification relates to a person(s) connected with the
director named in 2 above and identify the connected person(s)
6. Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary
7. Number of shares / amount of stock acquired
8. Percentage of issued class
9. Number of shares/amount of stock disposed
10. Percentage of issued class
11. Class of security
12. Price per share
13. Date of transaction
14. Date company informed
15. Total holding following this notification
16. Total percentage holding of issued class following this notification
If a director has been granted options by the company please complete the
following boxes.
17. Date of grant
25 September 2003
18. Period during which or date on which exercisable
Between 25 September 2006 and 24 September 2013
19. Total amount paid (if any) for grant of the option
N/a
20. Description of shares or debentures involved: class, number
Options over 200,000 Ordinary shares of 5 pence each
21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at time of exercise
663.8 pence
22. Total number of shares or debentures over which options held following this
notification
100, 000 options granted under the 1994 Executive Share Option scheme at an
exercise price of 677.57p between 30 October 2003 and 30 October 2010
300,000 options granted under the 2002 Executive Share Option Scheme at an
exercise price of 645.54p between 6 December 2005 and 5 December 2012
200,000 options granted on 25 September 2003 under the 2002 Executive Share
Option Scheme at an exercise
price of 663.8p between 25 September 2006 and 24 September 2103
Total = 600,000 options
23. Any additional information
24. Name of contact and telephone number for queries
Bonita Dryden - 020 7747 5681
25. Name and signature of authorised company official responsible for making
this notification
Date of Notification
26 September 2003
The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.